1.A Case of Sclerosing Angiomatoid Nodular Transformation of the Spleen: Spoke Wheel Pattern on Computed Tomography.
Joo Han PARK ; Sun Hyuk HWANG ; Ki Chan KIM ; Si Yeon KIM ; Ga Won SONG ; Jae Ho HAN ; Joon Seong PARK
Korean Journal of Medicine 2014;86(3):357-361
Sclerosing angiomatoid nodular transformation (SANT) is a rare, benign vascular neoplasm. Most patients have no clinical symptoms, and the tumors are usually discovered incidentally on abdominal computed tomography or ultrasonography. Some studies have reported the clinical features and imaging findings of SANT, but the diagnosis is based on histopathologic examination of a tissue specimen obtained at splenectomy. We report herein an incidentally discovered case of SANT and review the related literature.
Diagnosis
;
Humans
;
Spleen*
;
Splenectomy
;
Splenic Neoplasms
;
Ultrasonography
;
Vascular Neoplasms
2.A Case of Splenic Pseudocyst Difficult to Differentiate from Splenic Lymphangioma.
Shin Ae LEE ; Sang Young HAN ; Eun Joo LEE ; Byung Pyo KWON ; In Young KOH ; Hae Jong CHOI ; Min Chan KIM ; Jin Han CHO
The Korean Journal of Gastroenterology 2006;48(6):427-430
Splenic pseudocyst is a rare complication of abdominal trauma. Although it is rare, splenic pseudocyst is well-documented in the literature. According to the current classification, approximately 30% of all splenic cysts or pseudocysts result from direct abdominal trauma. In addition, chronic pancreatitis leads to change of nearby organs with possible acute and chronic complications including splenic lesions. This unusual complication can occur in both emergent and nonemergent conditions. The useful diagnostic procedures to assess intrasplenic pseudocyst are sonogram, CT scan, splenic scan, and occasionally angiography. However, definite diagnosis of pseudocyst is possible only after splenectomy when the absence of epithelial lining is confirmed histologically. Splenic pseudocyst requires surgical resection. We experienced a 31-year-old man who confirmed of warmness in the left side of back with left upper quadrant abdominal pain for several months. First impression was splenic lymphangioma based on CT scan and sonogram finding. Splenectomy was performed. Microscopic examination revealed splenic pseudocyst with fibrous capsule without epithelial lining.
Adult
;
Cysts/*diagnosis/radiography/ultrasonography
;
Diagnosis, Differential
;
Humans
;
Lymphangioma/diagnosis
;
Male
;
Splenectomy
;
Splenic Diseases/*diagnosis/radiography/ultrasonography
;
Splenic Neoplasms/diagnosis
;
Tomography, X-Ray Computed
3.Littoral cell angioma of the spleen: report of three cases and a review of the literature.
Xiao-Yan LIN ; Jia-Mei LI ; Qiang-Xiu WANG ; Ji-Zhen FENG ; Miao-Qing ZHAO ; Wei-Xia ZHONG ; Jian-Feng LI
Chinese Medical Journal 2011;124(20):3423-3426
Littoral cell angioma is a recently described rare vascular tumor of the spleen. The clinical course of this benign tumor is asymptomatic in most patients. Herein, we described three patients with littoral cell angioma detected during physical examination. A brief discussion and review of a handful of cases of splenic littoral cell angioma, which have been previously reported in the English language literature, are performed in this paper.
Female
;
Hemangioma
;
blood
;
diagnosis
;
pathology
;
Humans
;
Male
;
Middle Aged
;
Splenic Neoplasms
;
blood
;
diagnosis
;
pathology
4.Laparoscopic partial splenectomy for giant hemangioma misdiagnosed as splenic cyst: a case report.
Jin WANG ; Jian-Chun YU ; Wei-Ming KANG ; Zhi-Qiang MA
Chinese Medical Sciences Journal 2010;25(3):189-192
Cysts
;
diagnosis
;
Diagnostic Errors
;
Female
;
Hemangioma
;
diagnosis
;
surgery
;
Humans
;
Laparoscopy
;
methods
;
Middle Aged
;
Splenectomy
;
methods
;
Splenic Diseases
;
diagnosis
;
Splenic Neoplasms
;
surgery
5.Clinicopathologic features and diagnosis of metastatic carcinoma to the spleen.
Zhaoxiang ZHANG ; Zhong FANG ; Junping YE ; Caiyun TAO ; Muhua YI ; Hua LU
Chinese Journal of Surgery 2002;40(8):585-588
OBJECTIVETo study the clinicopathologic features and diagnosis of metastatic carcinoma to the spleen (MCS).
METHODSFour patients (1 man and 3 women, mean age 43.5 years) with MCS were analyzed clinicopathologically.
RESULTSThe four MCS patients accounted for 1.3% of 308 patients having spleen biopsy from 1959 to 1999. Their chief presentations were pain and mass in the left upper quadrant of the abdomen. The mass was located in the upper pole of the spleen (1 patient), the lower pole of the spleen (2), or the lower pole and hilum of the spleen (1). Macroscopically, all of the lesions were nodular. Histologic type of these MCSs included acinar cell carcinoma of the pancreas (2 patients), transverse colon adenocarcinoma (1), and hepatic cell carcinoma (1). Clinically, 1 patient was diagnosed as having MCS and 3 were misdiagnosed. According to Chinese literature, the clinicopathologic features of MCS were as follows: (1) 66.7% of the patients with MCS were aged 30 approximately 60 years, with a mean of 51.2 years. (2) 76.3% of the patients presented with pain in the left upper quadrant of the abdomen and 63.2% with splenomegaly and splenic masses. (3) Macroscopically, nodular lesions accounted for 68.4%. (4) Microscopically, 84.2% of the lesions were adenocarcinomas and 70.3% originated from carcinomas of the colon, liver, ovary and pancreas. (5) B-mode ultrasonography and/or CT showed occupying lesions or masses in the spleen in 76.7%, and MCS in 11.8%. (6) Clinically, 73.7% of the patients were misdiagnosed.
CONCLUSIONSMCS is uncommon but its clinical misdiagnosis rate is high. Image examination is of value in clinical diagnosis. Cooperation of clinicians and pathologists may enhance the diagnostic level of MCS.
Adult ; Female ; Humans ; Male ; Middle Aged ; Splenic Neoplasms ; diagnosis ; pathology ; secondary
6.Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors.
The Korean Journal of Internal Medicine 2010;25(3):227-236
Marginal zone B-cell lymphoma (MZL) is the second most common subtype of non-Hodgkin's lymphoma in Korea (17.3%). Mucosa-associated lymphoid tissue (MALT) can develop in almost any organ as a result of exposure to a persistent stimulus, such as chronic infection or certain autoimmune processes. Under conditions of prolonged lymphoid proliferation, a malignant clone may emerge, which is followed by the development of a MALT lymphoma. Whereas MALT lymphoma of the stomach is the most common and the most extensively studied, we focus on non-gastric MZL studies conducted in Korea that highlight the most recent advances with respect to MZL definition, etiology, clinical characteristics, natural history, treatment approaches, outcomes, and prognostic factors. Moreover, we discuss current organ-specific considerations and controversies, and identify areas for future research.
Humans
;
Korea
;
Lymphoma, B-Cell, Marginal Zone/*diagnosis/*therapy
;
Neoplasm Staging
;
Organ Specificity
;
Prognosis
;
Splenic Neoplasms/diagnosis/therapy
7.Sclerosing angiomatoid nodular transformation of the spleen: report of five cases and review of literature.
Hao-Lu WANG ; Ke-Wei LI ; Jian WANG
Chinese Medical Journal 2012;125(13):2386-2389
Sclerosing angiomatoid nodular transformation (SANT) of the spleen, a newly defined primary lesion of the spleen, is very rare. Immunohistochemistry is the only way to confirm the diagnosis of SANT. We present the clinical characteristics and postoperative outcomes of five SANT cases that underwent splenectomy from January 2007 to October 2010. Although SANT had specific imaging findings, differential diagnosis from other splenic tuomrs or malignant lesions preoperatively was difficult. The hand-assisted laparoscopic splenectomy was a useful and effective technique for the management and postoperative diagnosis of SANT. All SANT patients had good prognosis without recurrence after splenectomy.
Adult
;
Angiomatosis
;
diagnosis
;
pathology
;
surgery
;
Female
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Spleen
;
pathology
;
surgery
;
Splenic Neoplasms
;
diagnosis
;
pathology
;
surgery
8.Three Cases of Diffuse Large B-Cell Lymphoma Presenting as Primary Splenic Lymphoma.
Ja Kyung KIM ; Jee Sook HAHN ; Gwi Eon KIM ; Woo Ick YANG
Yonsei Medical Journal 2005;46(5):703-709
Primary splenic lymphoma (PSL) is often defined as generalized lymphoma with splenic involvement as the dominant feature. It is a rare disease that comprises approximately 1% of all malignant lymphomas. We investigated three cases of non-Hodgkin's splenic lymphoma that had different clinical features on presentation. The patients' survival times from diagnosis ranged from 59 to 143 months, without evidence of relapse after splenectomy and chemotherapy, with or without radiotherapy. This data suggest that PSL is potentially curable. Further studies are needed to evaluate the impact that different treatment modalities without splenectomy have on patient survival.
Splenic Neoplasms/*diagnosis/pathology/therapy
;
Splenectomy
;
Middle Aged
;
Male
;
Lymphoma, Large-Cell, Diffuse/*diagnosis/pathology/therapy
;
Lymphoma, B-Cell/*diagnosis/pathology/therapy
;
Humans
;
Female
10.Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry.
Yang HU ; Yan CHEN ; Li-Hua WANG ; Xue CHEN ; Fang FANG ; Shi-Qin LIU ; Xue-Qiang WU ; Ping ZHU ;
Journal of Experimental Hematology 2014;22(2):349-356
The splenic marginal zone lymphoma (SMZL) is a relatively rare chronic B lymphoproliferative disease, which primarily manifest increase of peripheral blood lymphocyte count and/or scale, and splenomegaly, while the peripheral superficial lymph nodes are often not swollen. Therefore, the splenectomy are usually needed to confirm the diagnosis, but the majority of patients could not accept such management, resulting in early difficult diagnosis. This study was purposed to explore the more prior way for diagnosis based flow cytometry (FCM). Six patients with suspected diagnosis of SMZL were used as research objects, 10 healthy bone marrow donors and 10 cases of chronic lymphocytic leukemia (CLL), 3 cases of hairy cell leukemia (HCL), 3 cases of lymphatic plasma cell lymphoma/Waldenströ's macroglobulinemia (LPL/WM) were selected as control. The immunophenotype of bone marrow cells were analyzed and compared by FCM using a panel of antibodies including CD45, CD5, CD10, CD19, CD20, CD22, CD23, CD25, CD103, CD11c, CD123, κ,λ, Cyclin D1, and combined with bone marrow cell morphology. The results indicated that 6 cases of suspected SMZL showed a large increase of lymphocytes and splenomegaly. Because absence of peripheral lymphadenopathy, 6 patients did not suffer from lymph node biopsy, only 1 patient underwent diagnostic splenectomy. The immunophenotypes of bone marrow in patients and controls were analyzed by FCM, as a result, except for the healthy donors, varying degrees of abnormal mature B cell clones were found in bone marrow of all patients, and the further differentiation from other B-cell tumors was performed through CD5, CD10 expression and combination with other B-cell phenotype. All 6 cases of SMZL patients expressed CD19(+) and CD20(+), but CD10 expression was negative, 4 patients expressed CD5(-), 2 patients expressed CD5(+). The expressions of CD23, CD38, ZAP-70, CD11c, CD103, CD123, Cyclin D1 were negative. The morphological examination of bone marrow cells showed velutinous abnormal lymphocytes. Combined with clinical characteristics, 6 patients were diagnosed as SMZL, 1 patient suffered from splenectomy because of concurrent hypersplenism, and this postoperative pathologic examination confirmed the patient with SMZL. Ten cases of CLL mainly expressed CD5, CD23; 3 cases of HCL had more typical morphology of "hair like" in addition to CD11c, CD103 and CD123 positive; 3 cases of LPL/WM had significantly increased light chain restriction expression, IgM, plasmacytoid lymphocytes. It is concluded that the FCM immunophenotype analysis can be used as a powerful tools for clinical diagnosis of SMZL.
Adult
;
Aged
;
Aged, 80 and over
;
B-Lymphocytes
;
Female
;
Flow Cytometry
;
Humans
;
Immunophenotyping
;
Lymphoma, B-Cell, Marginal Zone
;
diagnosis
;
Lymphoproliferative Disorders
;
diagnosis
;
Male
;
Middle Aged
;
Splenic Neoplasms
;
diagnosis